Literature DB >> 25624347

Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells.

Katsuya Nagaoka1, Shinjiro Hino2, Akihisa Sakamoto3, Kotaro Anan3, Ryuta Takase3, Takashi Umehara4, Shigeyuki Yokoyama4, Yutaka Sasaki5, Mitsuyoshi Nakao6.   

Abstract

Cells link environmental fluctuations, such as nutrition, to metabolic remodeling. Epigenetic factors are thought to be involved in such cellular processes, but the molecular basis remains unclear. Here we report that the lysine-specific demethylase 2 (LSD2) suppresses the flux and metabolism of lipids to maintain the energy balance in hepatic cells. Using transcriptome and chromatin immunoprecipitation-sequencing analyses, we revealed that LSD2 represses the genes involved in lipid influx and metabolism through demethylation of histone H3K4. Selective recruitment of LSD2 at lipid metabolism gene loci was mediated in part by a stress-responsive transcription factor, c-Jun. Intriguingly, LSD2 depletion increased the intracellular levels of many lipid metabolites, which was accompanied by an increased susceptibility to toxic cell damage in response to fatty acid exposure. Our data demonstrate that LSD2 maintains metabolic plasticity under fluctuating environment in hepatocytes by mediating the cross talk between the epigenome and metabolism.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25624347      PMCID: PMC4355535          DOI: 10.1128/MCB.01404-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

2.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

3.  A feed-forward circuit controlling inducible NF-κB target gene activation by promoter histone demethylation.

Authors:  Dominic van Essen; Yina Zhu; Simona Saccani
Journal:  Mol Cell       Date:  2010-09-10       Impact factor: 17.970

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 5.  JNK regulation of hepatic manifestations of the metabolic syndrome.

Authors:  Mark J Czaja
Journal:  Trends Endocrinol Metab       Date:  2010-10-01       Impact factor: 12.015

Review 6.  Modification of enhancer chromatin: what, how, and why?

Authors:  Eliezer Calo; Joanna Wysocka
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

7.  A novel mammalian flavin-dependent histone demethylase.

Authors:  Aristotele Karytinos; Federico Forneris; Antonella Profumo; Giuseppe Ciossani; Elena Battaglioli; Claudia Binda; Andrea Mattevi
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

8.  Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet.

Authors:  Igor P Pogribny; Volodymyr P Tryndyak; Tetyana V Bagnyukova; Stepan Melnyk; Beverly Montgomery; Sharon A Ross; John R Latendresse; Ivan Rusyn; Frederick A Beland
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

9.  Histone H3 lysine 4 monomethylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycaemic/hyperinsulinemic conditions in 3T3 cells.

Authors:  Jeena Gupta; Sandeep Kumar; Juntao Li; R Krishna Murthy Karuturi; Kulbhushan Tikoo
Journal:  Biochimie       Date:  2012-08-21       Impact factor: 4.079

10.  Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation.

Authors:  Dongning Pan; Chunxiao Mao; Yong-Xu Wang
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

View more
  15 in total

Review 1.  Decoding the rosetta stone of mitonuclear communication.

Authors:  Justin English; Jyung Mean Son; Maria Dafne Cardamone; Changhan Lee; Valentina Perissi
Journal:  Pharmacol Res       Date:  2020-08-23       Impact factor: 7.658

2.  The LSD1 Family of Histone Demethylases and the Pumilio Posttranscriptional Repressor Function in a Complex Regulatory Feedback Loop.

Authors:  Wayne O Miles; Julie M J Lepesant; Jessie Bourdeaux; Manuela Texier; Marc A Kerenyi; Makoto Nakakido; Ryuji Hamamoto; Stuart H Orkin; Nicholas J Dyson; Luisa Di Stefano
Journal:  Mol Cell Biol       Date:  2015-10-05       Impact factor: 4.272

3.  LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα.

Authors:  Kensaku Kohrogi; Shinjiro Hino; Akihisa Sakamoto; Kotaro Anan; Ryuta Takase; Hirotaka Araki; Yuko Hino; Kazutaka Araki; Tetsuya Sato; Kimitoshi Nakamura; Mitsuyoshi Nakao
Journal:  Blood Adv       Date:  2021-05-11

Review 4.  Linking Lipid Metabolism to Chromatin Regulation in Aging.

Authors:  Katharina Papsdorf; Anne Brunet
Journal:  Trends Cell Biol       Date:  2018-10-10       Impact factor: 20.808

5.  Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.

Authors:  Li-Hua Qu; Qian Fang; Tong Yin; Hui-Mei Yi; Guang-Bo Mei; Zi-Zhan Hong; Xue-Bing Qiu; Rui Zhou; Hui-Fen Dong
Journal:  Cancer Immunol Immunother       Date:  2022-03-07       Impact factor: 6.630

6.  Lysine-specific demethylase-2 is distinctively involved in brown and beige adipogenic differentiation.

Authors:  Ryuta Takase; Shinjiro Hino; Katsuya Nagaoka; Kotaro Anan; Kensaku Kohrogi; Hirotaka Araki; Yuko Hino; Akihisa Sakamoto; Thomas B Nicholson; Taiping Chen; Mitsuyoshi Nakao
Journal:  FASEB J       Date:  2019-01-25       Impact factor: 5.191

7.  Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.

Authors:  Satoshi Narahara; Takehisa Watanabe; Katsuya Nagaoka; Nahoko Fujimoto; Yoki Furuta; Kentaro Tanaka; Takayuki Tokunaga; Takeshi Kawasaki; Yoko Yoshimaru; Hiroko Setoyama; Kentaro Oniki; Junji Saruwatari; Masakuni Tateyama; Hideaki Naoe; Motohiko Tanaka; Yasuhito Tanaka; Yutaka Sasaki
Journal:  Hepatol Commun       Date:  2021-11-27

Review 8.  Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.

Authors:  Hideaki Niwa; Takashi Umehara
Journal:  Epigenetics       Date:  2017-02-10       Impact factor: 4.528

Review 9.  Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.

Authors:  Shinjiro Hino; Kensaku Kohrogi; Mitsuyoshi Nakao
Journal:  Cancer Sci       Date:  2016-09-01       Impact factor: 6.716

10.  LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation.

Authors:  Kotaro Anan; Shinjiro Hino; Noriaki Shimizu; Akihisa Sakamoto; Katsuya Nagaoka; Ryuta Takase; Kensaku Kohrogi; Hirotaka Araki; Yuko Hino; Shingo Usuki; Shinya Oki; Hirotoshi Tanaka; Kimitoshi Nakamura; Fumio Endo; Mitsuyoshi Nakao
Journal:  Nucleic Acids Res       Date:  2018-06-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.